Acrospire Investment Management LLC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 137 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
Acrospire Investment Management LLC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q2 2017$83,000
-7.8%
7,047
-14.2%
0.08%
+5.4%
Q1 2017$90,000
-62.0%
8,213
-74.8%
0.07%
-24.5%
Q4 2016$237,000
+59.1%
32,629
+42.4%
0.10%
-1.0%
Q3 2016$149,000
+16.4%
22,917
-2.4%
0.10%
+4.2%
Q2 2016$128,000
+88.2%
23,475
+61.9%
0.10%
+102.1%
Q1 2016$68,00014,5010.05%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,712,176$123,147,0006.01%
TANAKA CAPITAL MANAGEMENT INC 74,139$1,048,0003.38%
S&T BANK/PA 625,078$8,859,0001.92%
Parallel Advisors, LLC 1,277,851$18,062,0001.55%
AJ WEALTH STRATEGIES, LLC 595,828$8,422,0001.11%
Matarin Capital Management, LLC 891,636$12,603,0000.95%
Capital Impact Advisors, LLC 162,544$2,370,0000.90%
AMI ASSET MANAGEMENT CORP 775,685$10,964,0000.57%
Birchview Capital, LP 50,000$707,0000.47%
Zebra Capital Management LLC 25,409$359,0000.39%
View complete list of CORCEPT THERAPEUTICS INC shareholders